Byvalson--a beta blocker/ARB combination for hypertension.
D058665:Adrenergic beta-1 Receptor Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D004334:Drug Administration Schedule; D004338:Drug Combinations; D004347:Drug Interactions; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D000068577:Nebivolol / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D000068756:Valsartan / Q000008:administration & dosage / Q000627:therapeutic use*
D058665:Adrenergic beta-1 Receptor Agonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D004338:Drug Combinations; D000068577:Nebivolol; D000068756:Valsartan